NYSE:AMPE

Ampio Pharmaceuticals Stock Insider Trading

> Biotechnology

Buy AMPE

*Your capital is at risk

$0.183

+0 (+0%)

At Close: Jun 03, 2026

Ampio Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 9.13M and sold 661.13K AMPE shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	0
● Buy	9.13M shares
● Sell	661.13K shares
78% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 25, 2021 Buy	1. Stock Option (Right to Buy) M-Exempt	Stokely Dan CFO	C-Suite Officer	22 500 Value: $10K
May 21, 2021 Buy	Stock Option (Right to Buy) M-Exempt	Cherevka Holli Chief Operating Officer	C-Suite Officer	2 603 Value: $1K
May 21, 2021 Buy	Common Stock M-Exempt	Cherevka Holli Chief Operating Officer	C-Suite Officer	2 603 Value: $1K
May 21, 2021 Sell	Common Stock S-Sale	Cherevka Holli Chief Operating Officer	C-Suite Officer	2 603 Value: $5K
May 21, 2021 Buy	Common Stock M-Exempt	Coelho Philip H Director	Director	6 737 Value: $3K
May 21, 2021 Sell	Common Stock S-Sale	Coelho Philip H Director	Director	6 737 Value: $13.5K
May 21, 2021 Buy	Stock Option (Right to Buy) M-Exempt	Coelho Philip H Director	Director	6 737 Value: $3K
May 21, 2021 Buy	Stock Option (Right to Buy) M-Exempt	Coelho Philip H Director	Director	6 737 Value: $3K
May 21, 2021 Sell	Common Stock S-Sale	Coelho Philip H Director	Director	6 737 Value: $13.5K
May 21, 2021 Buy	Common Stock M-Exempt	Coelho Philip H Director	Director	6 737 Value: $3K
May 21, 2021 Sell	Common Stock S-Sale	Cherevka Holli Chief Operating Officer	C-Suite Officer	2 603 Value: $5K
May 21, 2021 Buy	Common Stock M-Exempt	Cherevka Holli Chief Operating Officer	C-Suite Officer	2 603 Value: $1K
May 21, 2021 Buy	Stock Option (Right to Buy) M-Exempt	Cherevka Holli Chief Operating Officer	C-Suite Officer	2 603 Value: $1K
May 18, 2021 Sell	Common Stock S-Sale	Stokely Dan CFO	C-Suite Officer	35 000 Value: $64.0K
May 18, 2021 Sell	Common Stock S-Sale	Stokely Dan CFO	C-Suite Officer	35 000 Value: $64.0K
May 17, 2021 Buy	Stock Option (Right to Buy) M-Exempt	Stokely Dan CFO	C-Suite Officer	35 000 Value: $15.1K
May 17, 2021 Buy	Common Stock M-Exempt	Stokely Dan CFO	C-Suite Officer	35 000 Value: $15.1K
May 17, 2021 Buy	Common Stock M-Exempt	Stokely Dan CFO	C-Suite Officer	35 000 Value: $15.1K
May 17, 2021 Buy	Stock Option (Right to Buy) M-Exempt	Stokely Dan CFO	C-Suite Officer	35 000 Value: $15.1K
Apr 29, 2021 Buy	Common Stock M-Exempt	Coelho Philip H Director	Director	3 263 Value: $1K
Apr 29, 2021 Sell	Common Stock S-Sale	Coelho Philip H Director	Director	3 263 Value: $7K
Apr 29, 2021 Buy	Stock Option (Right to Buy) M-Exempt	Coelho Philip H Director	Director	3 263 Value: $1K
Apr 27, 2021 Buy	Common Stock M-Exempt	Coelho Philip H Director	Director	20 000 Value: $8K
Apr 27, 2021 Sell	Common Stock S-Sale	Coelho Philip H Director	Director	20 000 Value: $40.0K
Apr 27, 2021 Buy	Stock Option (Right to Buy) M-Exempt	Coelho Philip H Director	Director	20 000 Value: $8K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT AMPIO PHARMACEUTICALS INC

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requi...

Read Full Profile Here